CELF™
CELF™ is composed of unit modules for each function of cell culture/proliferation, coating, cell collection, cell division, cell differentiation and c
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- L/C
- Production method
- ODM,OEM
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Other Equipment
Apply a video call to the Supplier
K-BioCELF Inc.
South Korea
- Verified Certificate
-
1
| Product name | CELF™ | Certification | - |
|---|---|---|---|
| Category | Other Equipment | Material | - |
| Keyword | stem cell , automated cell culture system , advanced biopharmaceutical , immune cell | Unit Size | - |
| Brand name | - | Unit Weigh | 800 kg |
| origin | South Korea | Stock | 0 |
| Supply type | ODM,OEM | HS code | - |
Product Information
Automated cell culture technology is a key technology that enables highquality cell culture in basic and applied research in a wide range of fields such as natural science and pharmaceutical engineering. In order to produce cell therapy products, cell culture, proliferation, and cell differentiation are basically required. However, the production of cell therapy products is different for each customer and there is a difference that all or part of the process is required. CELF™ is composed of unit modules for each function of cell culture/proliferation, coating, cell collection, cell division, cell differentiation and cell harvesting process.
Performance | Specification |
Inhalation/Dispensing | Cell : 1- 5 ㎖, Media ; 5 - 40 ㎖, PBS : 5 - 40 ㎖, Enzyme : 0.1 -1㎖ |
Centrifuge | •Less
than 3000 rpm •Well
plate, 50 ㎖ C-tube •Vision
for Cell Localization after Centrifugation |
Cell Observation | Phase Contrast Microscopy |
Cell Culture | CO2 Incubator |
Cleanliness | Class 100 |
B2B Trade
| Price (FOB) | Negotiable | transportation | Negotiation Other |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | L/C | Shipping time | Negotiable |
- President
- Oh Myung Ryurl
- Address
- #503, 77, Changnyong-daero 256beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea
- Product Category
- Other Equipment,Other Monitoring & Diagnostic Equipment
- Year Established
- 2019
- Company introduction
-
K-BioCELF Inc., was established in March 2019, and a Bio Venture company whose main businesses is the developments of technology based new drugs, in vitro Diagnosis and Automated Bioprocess Robotic Systems based on core technology.
Major products include CELB ACE™ System(Liquid Biopsy System, IVD), CELB™ SEP-STD (Automated Blood Separation System), CELP™ (Artificial Skin Model Production System), CELF™ (Advanced Biopharmaceuticals Production System), CELH™ DDR-SP (Reagent Dispensing System), CELH™ DST (Automated Microbial Inoculation System), and Molecular genetic diagnostic kits, and so on.
Advanced biopharmaceuticals: stem cells, iPSC-derived stem cells, organoids, immune cells (NK, T cells, etc.), and CGT (cell and gene therapeutics; CAR-T, CAR-NK, CAR-Macrophage, etc.).
- Main Markets
-
Canada
India
Indonesia
Thailand
U.S.A
- Main Product
- Attached File
